 Daily Mail | The great cancer betrayal: Number of treatments on approved list for patients ... Daily Mail The blood cancer drug, Rituximab, was the fourth most frequently requested treatment through the Fund last year. Andrew Wilson, chief executive of the Rarer Cancers Foundation, said: 'This appears to be a clear step backwards for cancer patients in ... |
